Natick, MA and San Francisco, CA-- Boston Scientific Corporation reports positive outcomes from the CABANA post-approval study of the Carotid WALLSTENT ® Monorail ® Endoprosthesis used in conjunction ...
Boston Scientific has recalled its Carotid Wallstent Monorail endoprosthesis, used to treat narrowed carotid arteries, due to a manufacturing defect that increases the risk of resistance when ...
Ordinarily when a study reveals that one device is as effective as the gold standard the news is considered good – but not fantastic – for the maker of the new device. But that's not at all Cook ...
PARIS, June 20 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today welcomed the results of a new study, led by Dr. Marc Bosiers of Belgium, demonstrating that the closed cell design of ...
With the introduction of self-expanding stents, an increased number of complex diseases were treated, with success rates comparable to those of open surgery. [14,15] In a contemporary study, the use ...
In the recent past, rigid plastic endoprostheses were used to palliate malignant dysphagia. However, these bulky devices required general anesthesia for placement and had a high complication rate. [1] ...
The U.S. FDA has announced a class I recall for the Wallstent Monorail system by Boston Scientific Corp. of Marlborough, Mass, a device for treatment of carotid artery stenosis. The company advised ...
Leading carotid stent in Europe and other international markets now available in the United States NATICK, Mass., Oct. 23 /PRNewswire-FirstCall/ -- Boston Scientific ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results